ClinicalTrials.gg
Sign In

Basal Ganglia Diseases clinical trials

The registry lists 40 studies for Basal Ganglia Diseases across more than 10 countries. 13 are recruiting or about to start. 2 of them are mainly about Basal Ganglia Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 9 narrower conditions too, such as Parkinson Disease: 5,579 studies, 1,323 open.

Get an email when these change. Save the Basal Ganglia Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
16
Recruiting
9
Status unknown
5
Terminated
3
Enrolling by invitation
2
Not yet recruiting
2

Phase

Phase 2
6
Phase 1
5
Phase 4
3
Phase 3
3
Early Phase 1
1

Where

United States
15
Italy
6
Germany
6
Canada
5
Netherlands
4
Sweden
3

Who runs them

Radboud University Medical Center (3) · Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · Siena Biotech S.p.A. (2) · Danish Research Centre for Magnetic Resonance (2) · Renishaw (1) · University of Colorado, Denver (1) · Fondazione Don Carlo Gnocchi Onlus (1) · Henri Mondor University Hospital (1)

What is being tested here

Drugs under test in Basal Ganglia Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ambroxol111
Selisistat002
Aripiprazole022
Pramipexole001
Whey Proteins001
Fipamezole001
Risperidone001
Olanzapine001
Bifidobacterium longum/Lactobacillus acidophilus/Enterococcus faecalis Probiotic Supplement001

Drug classes tested here Antipsychotics 3

Coming up

1phase 3 study under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 9 Basal Ganglia Diseases studies recruiting now, 4 (44%) set no upper age limit and 1 (11%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (11%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
100 (0%)0 (0%)
184 (44%)4 (44%)
304 (44%)4 (44%)
406 (67%)6 (67%)
509 (100%)9 (100%)
659 (100%)9 (100%)
759 (100%)9 (100%)
855 (56%)5 (56%)

Across all 40 studies, recruiting or not: 30% stop at 75 or younger and 13% at 65; 5% take children; 0% are for women only and 0% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 40 of 40. search them.